An open study with tiagabine in partial epilepsy;Estudio abierto con tiagabina en epilepsia parcial

Revista de Neurologia

Volumn 31, Issue 8, 2000, Pages 728-732

  Arroyo, S ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Anticonvulsant; Antiepileptic drugs; Epilepsy; Partial seizures; Tiagabine

Indexed keywords

ANTICONVULSIVE AGENT; NIPECOTIC ACID DERIVATIVE; TIAGABINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NIPECOTIC ACIDS; TREATMENT OUTCOME;

EID: 0034675474     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3108.2000383     Document Type: Article

References (3)

1. Suzdak PD, Jansen JA. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 1995; 36: 612-26.
2. Pfeiffer M, Draguhn A, Meierkord H, Heinemann U. Effects of gamma-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro. Br J Pharmacol 1996; 119: 569-77.
3. Dalby NO, Nielsen EB. Tiagabine exerts an anti-epileptogenic effect in amygdala kindling epileptogenesis in the rat. Neurosci Lett 1997; 229: 135-7.